ArticleArthroplasty today2024
Outcomes of Primary Total Hip Arthroplasty Using Custom Femoral Stems in Patients With Secondary Hip Osteoarthritis: A Systematic Review.
Article in Arthroplasty today, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This systematic review aims to evaluate the effectiveness and safety of custom femoral stems in primary total hip arthroplasty (THA) for patients with secondary osteoarthritis with abnormal hip anatomy. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, databases were systematically searched for studies published on primary THA utilizing custom femoral stems. Inclusion criteria were studies on patients with secondary osteoarthritis receiving custom stems, with outcomes including implant survival, revision rates, and functional scores. Data were extracted from eligible studies, with a focus on overall and cause-specific revision rates. Results: A total of 689 studies were screened, 13 met the inclusion criteria, encompassing 806 patients and 951 custom THA procedures. The collective follow-up period averaged 11.6 years, with a mean age of 44.6 years. The mean reoperation and revision rates were 6.9% (95% confidence interval [CI]: 3.24-10.13) and 8.25% (95% CI: 4.02-12.47), respectively. The mean intraoperative fracture rate was 3.23% (95% CI: 1.35-5.11), and the mean postoperative leg length discrepancy was 4.25 mm (95% CI: 1.57-6.93). The mean improvement of postoperative Harris Hip Score was 40.32 (range 30-56). Conclusions: Custom femoral stems in primary THA demonstrate promising results in terms of implant survival and functional outcomes for patients with complex hip anatomy due to secondary osteoarthritis. These findings support the consideration of custom implants as a viable option for this patient demographic, although further research is warranted for long-term outcomes and direct comparisons with standard prostheses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.